A retrospective study by the National Institutes of Health (NIH) suggests that healthcare costs for those with rare diseases have been underestimated, possibly being three to five times higher than for those without rare diseases. This study provides evidence of the potential effect rare diseases may have on public health and healthcare systems, and suggests [ŝThe post NIH Study: Cost of Treating Rare Diseases ьargeҠRelative to Other Ills appeared first on Cystic Fibrosis News Today